Glass House Brands (GLAS) Free Cash Flow (QoQ) (2020 - 2026)
Glass House Brands (GLAS) Free Cash Flow (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Glass House Brands | 837.25 Mn | 818.69 Mn | 15.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 67.28% |
| Dec 31, 2025 | -803.45% |
| Sep 30, 2025 | -86.89% |
| Jun 30, 2025 | 196.69% |
| Mar 31, 2025 | 193.19% |
| Dec 31, 2024 | -167.41% |
| Sep 30, 2024 | 13.89% |
| Jun 30, 2024 | 2,317.36% |
| Mar 31, 2024 | 111.52% |
| Dec 31, 2023 | -100.00% |
| Sep 30, 2023 | 270,296,871.56% |
| Jun 30, 2023 | 45.26% |
| Mar 31, 2023 | 100.00% |
| Dec 31, 2022 | -147,749,057.41% |
| Sep 30, 2022 | 5,687.94% |
| Jun 30, 2022 | -93.04% |
| Mar 31, 2022 | -100.00% |
| Dec 31, 2021 | 19,245,068.57% |
| Sep 30, 2021 | 6,570.41% |
| Jun 30, 2021 | 635.87% |